Cabotegravir and Rilpivirine: A Long-Acting Injectable Antiretroviral Treatment for Human Immunodeficiency Virus.

Adam Leonard, Janessa Broussard, Natalie Wilson, Carol Dawson-Rose. Cabotegravir and Rilpivirine: A Long-Acting Injectable Antiretroviral Treatment for Human Immunodeficiency Virus. The Journal for Nurse Practitioners. 2022 Jan 1; 18(1):17-21.

2022
https://researcherprofiles.org/profile/344526825

Adam Leonard, Janessa Broussard, Natalie Wilson, Carol Dawson-Rose